ArticleThe Korean journal of internal medicine2023

Inflammation is responsible for systemic bone loss in patients with seropositive rheumatoid arthritis treated with rituximab.

Mie Jin Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.